Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein

Published:2010-03 Issue:12 Volume:55 Page:1266-1273
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ridker Paul M.,MacFadyen Jean,Cressman Michael,Glynn Robert J.

Funder

National Heart Lung and Blood Institute

National Cancer Institute

Donald W. Reynolds Foundation

Leducq Foundation

AstraZeneca

Novartis

Merck

Abbott

Roche

Sanofi-Aventis

National Heart, Lung, and Blood Institute

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification;Levey;Ann Intern Med,2003

3. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention;Sarnak;Circulation,2003

4. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis;Wanner;N Engl J Med,2005

5. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis;Fellstrom;N Engl J Med,2009

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap;Nephrology;2024-04-29

2. Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk;Journal of Clinical Medicine;2024-03-25

3. Benefits of statin therapy within a year after kidney transplantation;Scientific Reports;2024-01-23

4. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease;JAMA Network Open;2023-12-06

5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3